Resectable Pancreatic Adenocarcinoma Clinical Trials in Oklahoma City, Oklahoma
2 recruitingOklahoma City, Oklahoma
Showing 1–2 of 2 trials
Recruiting
Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell CarcinomaResectable Pancreatic CarcinomaResectable Pancreatic Adenocarcinoma+4 more
National Cancer Institute (NCI)152 enrolled453 locationsNCT04858334
Recruiting
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Resectable Pancreatic Adenocarcinoma
University of Oklahoma100 enrolled1 locationNCT05275075